Results 101 to 105 of about 252 (105)

The effect of NeuroAiD™ (MLC601) on cerebral blood flow velocity in subjects' post brain infarct in the middle cerebral artery territory

European Journal of Internal Medicine, 2011
Stroke is the third common cause of mortality and the most common cause of morbidity in adults. MLC601 (NeuroAiD™) is a treatment indicated for post stroke recovery. An increase of impaired cerebral blood flow may be an important parameter for recovery processes.
Reza, Bavarsad Shahripour, Gholamreza, Shamsaei, Hosein, Pakdaman, Nastaran, Majdinasab, Ehsan Mohammadiani, Nejad, Seyed Aidin, Sajedi, Mehdi, Norouzi, Ahmad, Hemmati, Reza Haj, Manouchehri, Abolfazl, Shiravi   +9 more
openaire   +2 more sources

Safety and efficacy of MLC601/MLC901 (NeuroAiD) amongst patients who sustain severe spinal cord injury (SATURN study)

Journal of the Neurological Sciences, 2021
Htwe Ohnmar, Ramesh Kumar, Azmi Baharudin, Hisam Ariffin, Muhindra Gsangaya, Hezery Harun, Khairrudin Kandar, Maatharasi Balan   +7 more
openaire   +1 more source

Effects of MLC601 on early recurrent vascular events in post-stroke patients —/INS; The chimes study

Journal of the Neurological Sciences, 2013
C. Chen, N. Venketasubramanian, C.F. Lee, K.S.L. Wong, M.-G. Bousser   +4 more
openaire   +1 more source

MLC601/MLC901, issu de la médecine chinoise induit de puissantes propriétés neuroprotectrices et neurorégénératives face à l’ischémie cérébrale chez le rongeur

Revue Neurologique, 2012
Hervé Quintard, Marc Borsotto, Catherine Widmann, Carine Gandin, Michel Lazdunski, Catherine Heurteaux   +5 more
openaire   +1 more source

LONG TERM SYNERGISTIC EFFECT OF COMBINING MLC601 AND REHABILITATION ON POST-STROKE RECOVERY -THE CHIMES-E STUDY

2018
openaire   +1 more source